loadpatents
Patent applications and USPTO patent grants for Reik; Andreas.The latest application filed is for "nuclease-mediated regulation of gene expression".
Patent | Date |
---|---|
Methods and compositions for modulating PD1 Grant 11,235,026 - Gregory , et al. February 1, 2 | 2022-02-01 |
Nuclease-mediated Regulation Of Gene Expression App 20210348143 - Orkin; Stuart H. ;   et al. | 2021-11-11 |
Nuclease-mediated regulation of gene expression Grant 11,021,696 - Orkin , et al. June 1, 2 | 2021-06-01 |
Method Of Inactivating A Glucocorticoid Receptor Gene In An Isolated Cell App 20210102222 - Reik; Andreas ;   et al. | 2021-04-08 |
Methods And Compositions For Modification Of A Hla Locus App 20210054046 - Collingwood; Trevor ;   et al. | 2021-02-25 |
Isolated human cell with an inactivated glucocorticoid receptor gene Grant 10,907,175 - Reik , et al. February 2, 2 | 2021-02-02 |
Nuclease-mediated Regulation Of Gene Expression App 20210024606 - Reik; Andreas | 2021-01-28 |
Methods and compositions for modification of a HLA locus Grant 10,858,416 - Collingwood , et al. December 8, 2 | 2020-12-08 |
Nuclease-mediated regulation of gene expression Grant 10,808,020 - Reik October 20, 2 | 2020-10-20 |
Methods And Compositions For Increasing Rna Activity In A Cell App 20200318140 - Tan; Siyuan ;   et al. | 2020-10-08 |
Nuclease-mediated regulation of gene expression Grant 10,619,154 - Reik , et al. | 2020-04-14 |
Chimeric Antigen Receptor Mediated Cell Targeting App 20190048060 - Conway; Anthony ;   et al. | 2019-02-14 |
Methods and compositions for treatment of a genetic condition Grant 10,196,651 - Conway , et al. Fe | 2019-02-05 |
Methods and compositions for treatment of a genetic condition Grant 10,196,652 - Conway , et al. Fe | 2019-02-05 |
Methods And Compositions For Modulating Pd1 App 20180326000 - Gregory; Philip D. ;   et al. | 2018-11-15 |
Methods And Compositions For Modification Of A Hla Locus App 20180319864 - Collingwood; Trevor ;   et al. | 2018-11-08 |
Methods and compositions for treatment of a beta thalessemia Grant 10,072,066 - Liu , et al. September 11, 2 | 2018-09-11 |
Methods and compositions for modification of a HLA locus Grant 10,072,062 - Collingwood , et al. September 11, 2 | 2018-09-11 |
Nuclease-mediated Regulation Of Gene Expression App 20180237768 - Reik; Andreas ;   et al. | 2018-08-23 |
Methods and compositions for modulating PD1 Grant 10,046,028 - Gregory , et al. August 14, 2 | 2018-08-14 |
Methods And Compositions For Treatment Of A Genetic Condition App 20180223311 - Cost; Gregory J. ;   et al. | 2018-08-09 |
Methods And Compositions For Treatment Of A Genetic Condition App 20180148740 - Conway; Anthony ;   et al. | 2018-05-31 |
Methods and compositions for treatment of a genetic condition Grant 9,963,715 - Cost , et al. May 8, 2 | 2018-05-08 |
Methods And Compositions For Treatment Of A Genetic Condition App 20180119175 - Conway; Anthony ;   et al. | 2018-05-03 |
Nuclease-mediated regulation of gene expression Grant 9,957,501 - Reik , et al. May 1, 2 | 2018-05-01 |
Nuclease-mediated Regulation Of Gene Expression App 20180111975 - Reik; Andreas | 2018-04-26 |
Methods and compositions for treatment of a genetic condition Grant 9,902,974 - Conway , et al. February 27, 2 | 2018-02-27 |
Methods and compositions for treatment of a genetic condition Grant 9,873,894 - Conway , et al. January 23, 2 | 2018-01-23 |
Methods And Compositions For Increasing Rna Activity In A Cell App 20170137845 - Tan; Siyuan ;   et al. | 2017-05-18 |
Methods and compositions for treatment of a genetic condition Grant 9,650,648 - Cost , et al. May 16, 2 | 2017-05-16 |
Nuclease-mediated Regulation Of Gene Expression App 20160369262 - Reik; Andreas ;   et al. | 2016-12-22 |
Methods And Compositions For Modulating Pd1 App 20160220634 - Gregory; Philip D. ;   et al. | 2016-08-04 |
Methods and compositions for modulating PD1 Grant 9,402,879 - Gregory , et al. August 2, 2 | 2016-08-02 |
Methods And Compositions For Treatment Of A Genetic Condition App 20160090607 - Conway; Anthony ;   et al. | 2016-03-31 |
Method Of Inactivating A Glucocorticoid Receptor Gene In An Isolated Cell App 20160076056 - Reik; Andreas ;   et al. | 2016-03-17 |
Method of inactivating a glucocorticoid receptor gene in an isolated cell Grant 9,217,026 - Reik , et al. December 22, 2 | 2015-12-22 |
Methods And Compositions For Modification Of A Hla Locus App 20150252094 - Collingwood; Trevor ;   et al. | 2015-09-10 |
Methods And Compositions For Treatment Of A Beta Thalessemia App 20150218253 - Liu; Pei-Qi ;   et al. | 2015-08-06 |
Nuclease-mediated Regulation Of Gene Expression App 20150132269 - Orkin; Stuart H. ;   et al. | 2015-05-14 |
Methods And Compositions For Treatment Of A Genetic Condition App 20150056705 - Conway; Anthony ;   et al. | 2015-02-26 |
Methods and compositions for modification of a HLA locus Grant 8,945,868 - Collingwood , et al. February 3, 2 | 2015-02-03 |
Methods And Compositions For Treatment Of A Genetic Condition App 20140093913 - Cost; Gregory J. ;   et al. | 2014-04-03 |
Methods And Compositions For Treatment Of A Genetic Condition App 20140080216 - Cost; Gregory J. ;   et al. | 2014-03-20 |
Methods And Compositions For Modulating Pd1 App 20140030240 - Gregory; Philip D. ;   et al. | 2014-01-30 |
Methods and compositions for modulating PD1 Grant 8,563,314 - Gregory , et al. October 22, 2 | 2013-10-22 |
Methods And Compositions For Modification Of A Hla Locus App 20120060230 - Collingwood; Trevor ;   et al. | 2012-03-08 |
Methods and compositions for modulating PD1 App 20110136895 - Gregory; Philip D. ;   et al. | 2011-06-09 |
Methods and compositions for modification of the human glucocorticoid receptor locus App 20080188000 - Reik; Andreas ;   et al. | 2008-08-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.